성장을 멈추지 마세요

체험은 만족하셨나요?

현재 45,775명이 마이메르시로 공부 중이에요

지식 자료를 소장하고 멋진 의료인으로 성장하세요

학습 자료 둘러보기 →
Medications for Benign Prostatic Hyperplasia | 마이메르시 MyMerci
제안하기

뭔가 하고 싶은 말이 있는거야?

0 / 2000
컨텐츠 수정하기

컨텐츠 내용을 수정할 수 있습니다

수정하기
닫기

Medications for Benign Prostatic Hyperplasia

NCLEX Review Guide: Benign Prostatic Hyperplasia (BPH) Medications

Pathophysiology Overview

Understanding BPH

  • Benign Prostatic Hyperplasia (BPH) is a non-cancerous enlargement of the prostate gland that commonly affects men over 50 years of age. The enlarged prostate compresses the urethra, causing urinary obstruction and retention.
  • Primary symptoms include urinary frequency, urgency, nocturia, hesitancy, weak stream, and incomplete bladder emptying. These symptoms are collectively known as lower urinary tract symptoms (LUTS).

Key Points

  • BPH is age-related and affects approximately 50% of men by age 60 and 90% by age 85.
  • Symptoms result from both static (physical enlargement) and dynamic (increased smooth muscle tone) components of obstruction.

Alpha-1 Adrenergic Antagonists

Mechanism and Drug Examples

  • Alpha-1 adrenergic antagonists block alpha-1 receptors in the prostate and bladder neck, relaxing smooth muscle and improving urine flow without affecting prostate size.
  • Common medications include tamsulosin (Flomax), alfuzosin (Uroxatral), doxazosin (Cardura), and terazosin (Hytrin). These medications primarily address the dynamic component of BPH.

Alpha-1 Antagonist Comparison

Medication Selectivity Dosing Special Considerations
Tamsulosin (Flomax) Alpha-1A selective 0.4-0.8 mg once daily Less orthostatic hypotension; take 30 min after same meal each day
Alfuzosin (Uroxatral) Non-selective 10 mg once daily Extended-release; take with food
Doxazosin (Cardura) Non-selective 1-8 mg once daily Also used for hypertension; titrate dose
Terazosin (Hytrin) Non-selective 1-10 mg once daily Also used for hypertension; titrate dose

Key Points

  • Alpha-1 antagonists provide rapid symptom relief (within 1-2 weeks) compared to other BPH medications.
  • Tamsulosin is uroselective (targets primarily prostate tissue) and has fewer cardiovascular side effects than non-selective agents.

Important Alert: First-Dose Phenomenon

Non-selective alpha blockers (doxazosin, terazosin) can cause significant orthostatic hypotension with the first dose. Always instruct patients to take the first dose at bedtime and to rise slowly from lying or sitting positions.

Memory Aid: "FAINT" Side Effects of Alpha Blockers

F - First-dose syncope
A - Asthenia (weakness)
I - Impaired ejaculation
N - Nasal congestion
T - Tiredness/dizziness

5-Alpha Reductase Inhibitors

Mechanism and Drug Examples

  • 5-alpha reductase inhibitors (5-ARIs) block the conversion of testosterone to dihydrotestosterone (DHT), reducing prostate size by 20-30% over 6-12 months. These medications address the static component of BPH.
  • Examples include finasteride (Proscar) and dutasteride (Avodart). Dutasteride inhibits both type 1 and type 2 5-alpha reductase enzymes, while finasteride inhibits only type 2.

Key Points

  • 5-ARIs take 3-6 months to show clinical improvement and work best in men with significantly enlarged prostates (>40g).
  • These medications reduce serum PSA levels by approximately 50%, which must be considered when screening for prostate cancer.

Important Alert: Pregnancy Category X

Finasteride and dutasteride are pregnancy category X. Women who are or may become pregnant should not handle crushed or broken tablets due to potential fetal harm (risk of genital abnormalities in male fetuses).

Memory Aid: "SEEDS" - Side Effects of 5-ARIs

S - Sexual dysfunction (decreased libido)
E - Ejaculatory disorders
E - Erectile dysfunction
D - Decreased PSA levels (by ~50%)
S - Slow onset of action (3-6 months)

Combination Therapy

Dual Mechanism Approach

  • Combination therapy with an alpha-1 antagonist and a 5-alpha reductase inhibitor provides more effective symptom relief than either medication alone for men with larger prostates and moderate-to-severe symptoms.
  • Common combinations include dutasteride/tamsulosin (Jalyn) or separate prescriptions of finasteride and an alpha blocker.

Key Points

  • Combination therapy is most beneficial for men with prostate volumes >40g and moderate-to-severe symptoms.
  • The combination provides both immediate symptom relief (alpha blocker) and long-term prostate size reduction (5-ARI).

Clinical Scenario

A 68-year-old male presents with urinary hesitancy, weak stream, and nocturia (4-5 times nightly). His prostate is significantly enlarged on digital rectal exam. His PSA is 3.2 ng/mL. The provider starts him on tamsulosin 0.4 mg daily and finasteride 5 mg daily.

Nursing Considerations: Educate the patient that tamsulosin will provide relatively quick symptom relief while finasteride will work over months to reduce prostate size. Advise him about possible sexual side effects and the importance of follow-up PSA testing (with awareness that finasteride will lower PSA values).

Other Medication Options

Phosphodiesterase-5 (PDE-5) Inhibitors

  • PDE-5 inhibitors like tadalafil (Cialis) are FDA-approved for treating BPH symptoms. They relax smooth muscle in the prostate and bladder neck, improving urinary symptoms.
  • Tadalafil 5 mg daily is particularly beneficial for men with coexisting BPH and erectile dysfunction.

Anticholinergic Agents

  • Anticholinergics may be used cautiously in men with BPH who have predominant irritative symptoms (frequency, urgency) without significant obstruction.
  • Examples include oxybutynin (Ditropan), tolterodine (Detrol), and solifenacin (VESIcare). These must be used with caution due to risk of urinary retention.

Key Points

  • PDE-5 inhibitors should not be used concurrently with alpha blockers like doxazosin or terazosin due to risk of severe hypotension.
  • Anticholinergics are contraindicated in patients with significant urinary retention or high post-void residual volumes.

Important Alert: Beta-Sitosterol and Saw Palmetto

Many patients self-medicate with herbal supplements like saw palmetto or beta-sitosterol. Evidence for efficacy is limited and inconsistent. These supplements may interact with prescribed medications and should be disclosed to healthcare providers.

Nursing Considerations

Administration and Monitoring

  1. Assess baseline urinary symptoms using standardized tools like the International Prostate Symptom Score (IPSS).
  2. Monitor for orthostatic hypotension when initiating alpha blockers (especially non-selective ones).
  3. Evaluate for drug interactions, particularly with antihypertensives, erectile dysfunction medications, and certain antidepressants.
  4. Measure post-void residual volumes to assess for urinary retention.
  5. Monitor PSA levels, adjusting for the effect of 5-ARIs (double the measured PSA value for men on these medications).

Patient Education

  • Instruct patients on potential side effects, especially sexual dysfunction with 5-ARIs and orthostatic hypotension with alpha blockers.
  • Advise patients taking tamsulosin to take it 30 minutes after the same meal each day for consistent absorption.
  • Inform patients that 5-ARIs require several months for full effect, while alpha blockers typically work within days to weeks.
  • Caution against abrupt discontinuation of BPH medications, which can lead to acute urinary retention.

Key Points

  • Advise patients to report worsening symptoms, urinary retention, hematuria, or new-onset back pain, which may indicate complications or progression.
  • Counsel patients on non-pharmacological interventions: limiting evening fluids, avoiding alcohol and caffeine, double-voiding, and scheduled voiding.

Clinical Scenario

A 72-year-old male on tamsulosin for BPH is scheduled for cataract surgery. The ophthalmologist notes concern about intraoperative floppy iris syndrome (IFIS).

Nursing Considerations: Educate the patient that alpha blockers, particularly tamsulosin, can cause IFIS during cataract surgery. The ophthalmologist should be informed about tamsulosin use before surgery, as it may require surgical technique modifications. Typically, tamsulosin is not discontinued preoperatively, as the risk persists even after stopping the medication.

Commonly Confused Points

Alpha Blockers vs. 5-Alpha Reductase Inhibitors

Characteristic Alpha-1 Blockers 5-Alpha Reductase Inhibitors
Mechanism Relax prostate smooth muscle Shrink prostate tissue
Onset of action Rapid (days to weeks) Slow (3-6 months)
Effect on PSA No effect Reduces by approximately 50%
Primary side effects Orthostatic hypotension, dizziness, retrograde ejaculation Sexual dysfunction, gynecomastia
Best for All prostate sizes, immediate symptom relief Enlarged prostates (>40g), long-term management

Selective vs. Non-selective Alpha Blockers

Characteristic Selective (Tamsulosin, Silodosin) Non-selective (Doxazosin, Terazosin)
Target receptors Primarily alpha-1A (prostate-specific) All alpha-1 receptors (including vascular)
Blood pressure effects Minimal Significant (used to treat hypertension)
First-dose phenomenon Uncommon Common (requires dose titration)
Dosing considerations Take with food at same time daily Start with low dose at bedtime, then titrate

Key Points

  • Finasteride and dutasteride differ in that dutasteride inhibits both type 1 and type 2 5-alpha reductase enzymes, while finasteride inhibits only type 2.
  • BPH medications and ED medications (PDE-5 inhibitors) can interact; tadalafil is approved for both conditions but should not be used with alpha blockers except tamsulosin at the 0.4 mg dose.

Common Pitfalls

Don't confuse alpha-1 blockers (e.g., tamsulosin) with beta blockers (e.g., metoprolol). Alpha-1 blockers target the prostate and may cause orthostatic hypotension, while beta blockers target the heart and may cause bradycardia and bronchospasm.

Study Tips

Prioritizing BPH Medication Knowledge

  • Focus on understanding the two main classes (alpha blockers and 5-ARIs) and their distinct mechanisms, timing of effect, and side effect profiles.
  • Know the "selective" versus "non-selective" alpha blockers and their cardiovascular implications.
  • Memorize key nursing considerations, especially first-dose phenomenon with non-selective alpha blockers and pregnancy precautions with 5-ARIs.

Memory Aid: "ALPHA" for Alpha Blocker Characteristics

A - Acts quickly (days to weeks)
L - Lowers urinary symptoms without changing prostate size
P - Postural hypotension (especially non-selective)
H - Hesitancy and weak stream improve
A - Avoid abrupt discontinuation

Memory Aid: "5-ARIS" for 5-Alpha Reductase Inhibitors

5 - 5-6 months for full effect
A - Androgen (DHT) levels decrease
R - Reduce prostate size by 20-30%
I - Impact PSA (reduces by 50%)
S - Sexual dysfunction side effects

Quick Check: BPH Medications

1. Which medication would provide the fastest symptom relief for BPH?
a) Finasteride
b) Tamsulosin
c) Dutasteride
d) Saw palmetto

2. A patient taking finasteride has a PSA level of 2.0 ng/mL. What is the adjusted PSA value?
a) 1.0 ng/mL
b) 2.0 ng/mL
c) 4.0 ng/mL
d) 8.0 ng/mL

3. Which medication is most likely to cause orthostatic hypotension?
a) Tamsulosin
b) Finasteride
c) Terazosin
d) Dutasteride

Answers: 1. b, 2. c, 3. c

Self-Assessment Checklist

Remember, understanding BPH medications is crucial for male patient care across all clinical settings. Mastering these medications will help you provide safe, effective care and education. You're building important knowledge that will serve your patients well throughout your nursing career!

다음 이론을 계속 학습하려면 로그인하세요.

로그인하고 계속 학습
컨텐츠를 그만볼래?

필기노트, 하이라이터, 메모는 잘 쓰고 있어?

내보내줘
어떤 폴더에 저장할래?

컨텐츠 노트에는 총 0개의 폴더가 있어!

폴더 만들기
컨텐츠 만들기
만들기
신고했어요.

운영진이 검토할게요!

해당 유저를 차단했어요.

마이페이지에서 차단한 회원을 관리할 수 있어요.